Form D · Pharmaceuticals
Sea Pharmaceuticals, LLC
Cambridge, MA · CIK 0001667677
Offering snapshot reported May 20, 2026 · SEC filing
- Reported sold
- $71.1K Offering amount: $1.74M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $7.5K Reported outside-investor minimum
- First sale
- Jul 17, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 7
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 20, 2026 | Amendment | $71,100 | No comparison | 7 | SEC filing |
| May 14, 2025 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Feb 11, 2025 | Amendment | $417,380 | No comparison | 16 | SEC filing |
| Oct 11, 2023 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jan 26, 2023 | Amendment | $1,490,435 | $402,742vs Jan 14, 2022 | 27 | SEC filing |
| Jan 14, 2022 | Amendment | $1,087,693 | $459,806vs Feb 1, 2021 | 26 | SEC filing |
| Feb 1, 2021 | Amendment | $627,887 | $364,118vs Jan 31, 2020 | 19 | SEC filing |
| Jan 31, 2020 | Amendment | $263,769 | No comparison | 13 | SEC filing |
| Feb 27, 2019 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Nov 17, 2017 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Nov 16, 2016 | Amendment | $887,000 | $687,000vs Feb 29, 2016 | 38 | SEC filing |
| Feb 29, 2016 | Initial | $200,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-546144
Source: Form D, filed May 20, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| W. Kendall Brown | Director |
| Walter Kendall Brown | Director |
| Benjamin F Cravatt | Director |
| Mark G. Currie | Director |
| Nabil Elkouh | Director |
| Michael J. Higgins | Director |
| Eduardo J. Martinez | Executive |
| Eric R Olson | Director |
| James P. Pearson | Director, Executive |
| Shaker Sadasivam | Director |
| Anne M. Sullivan | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
14 Gray Street
Cambridge, MA, 02138
Phone: (617)838-5082
Cambridge, MA, 02138
Phone: (617)838-5082